2026-10-15T23:13:17Z https://data.mendeley.com/oai

oai:data.mendeley.com/wf4g3yxvzz.1 2022-10-14T18:34:20Z

Stein Gold, Linda Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients With Mild-to-Moderate Psoriasis Up to 32 Weeks: Results From the Extension Phase of the Randomized, Phase 3 ADVANCE Trial Mendeley Data Mendeley Supplemental Figures for Stein Gold et al. Efficacy and Safety of Apremilast in Patients With Mild-to-Moderate Psoriasis Up to 32 Weeks: Results From the Extension Phase of the Randomized, Phase 3 ADVANCE Trial. J Am Acad Dermatol. 2022. Clinical Trial Scalp Psoriasis Quality of Life Pruritus Papp, Kim Pariser, David Bhatia, Neal Sofen, Howard Albrecht, Lorne gooderham, melinda Callis Duffin, Kristina Chen, Mindy Paris, Maria Cheng, Sue Picard, Hernan Wang, Yao Green, Lawrence Dataset doi:10.17632/wf4g3yxvzz.1 oai:data.mendeley.com/wf4g3yxvzz.1 Creative Commons Attribution 4.0 International http://creativecommons.org/licenses/by/4.0 https://data.mendeley.com/datasets/wf4g3yxvzz 2022-10-14T18:34:20Z